Nu Skin Enterprises (NYSE:NUS) Issues Earnings Results

Nu Skin Enterprises (NYSE:NUS) posted its earnings results on Friday. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01), FiscalAI reports. Nu Skin Enterprises had a return on equity of 8.14% and a net margin of 10.79%.The business had revenue of $320.61 million for the quarter, compared to the consensus estimate of $329.70 million.

Nu Skin Enterprises Trading Up 1.6%

NUS stock traded up $0.11 during midday trading on Friday, hitting $7.13. The stock had a trading volume of 784,355 shares, compared to its average volume of 514,402. The firm has a market cap of $343.31 million, a P/E ratio of 2.23 and a beta of 1.03. The company has a current ratio of 2.08, a quick ratio of 1.40 and a debt-to-equity ratio of 0.25. Nu Skin Enterprises has a 1-year low of $6.34 and a 1-year high of $14.62. The business has a fifty day moving average price of $7.48 and a two-hundred day moving average price of $9.21.

Nu Skin Enterprises Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 10th. Investors of record on Friday, May 29th will be issued a $0.06 dividend. The ex-dividend date is Friday, May 29th. This represents a $0.24 annualized dividend and a yield of 3.4%. Nu Skin Enterprises’s payout ratio is presently 7.50%.

Hedge Funds Weigh In On Nu Skin Enterprises

Several hedge funds and other institutional investors have recently bought and sold shares of NUS. Amundi lifted its holdings in Nu Skin Enterprises by 18.8% in the first quarter. Amundi now owns 18,564 shares of the company’s stock valued at $127,000 after buying an additional 2,941 shares during the period. AQR Capital Management LLC lifted its holdings in Nu Skin Enterprises by 64.6% in the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company’s stock valued at $2,530,000 after buying an additional 137,475 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Nu Skin Enterprises during the 1st quarter valued at $162,000. Goldman Sachs Group Inc. boosted its stake in Nu Skin Enterprises by 7.2% during the first quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company’s stock worth $9,582,000 after acquiring an additional 88,088 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Nu Skin Enterprises by 9.3% in the second quarter. JPMorgan Chase & Co. now owns 764,052 shares of the company’s stock worth $6,105,000 after purchasing an additional 65,060 shares during the period. Institutional investors and hedge funds own 82.84% of the company’s stock.

More Nu Skin Enterprises News

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.06/share (annualized yield ~3.6%), payable June 10 to holders of record May 29 — supports income seekers and signals capital return priority. Dividend Announcement
• Neutral Sentiment: Company said Q1 revenue of $320.6M was within its guidance range, and provided slide deck/press materials for the quarter — useful for digging into channel and regional detail. Q1 Press Materials
• Neutral Sentiment: Stonegate Capital Partners updated coverage and reiterated results context (reported adj. NI and adj. EPS figures) — shows analyst attention but no headline rating/action in the release. Stonegate Coverage Update
• Neutral Sentiment: Full Q1 earnings call transcript is available for investors who want management commentary on trends (customer counts, FX, product mix). Useful for assessing whether weakness is cyclical or structural. Earnings Call Transcript
• Negative Sentiment: Q1 EPS of $0.14 missed the consensus $0.15 and declined from $0.23 a year ago; revenue of $320.6M missed consensus ~$329.7M — a modest earnings and top?line shortfall that pressured sentiment. Earnings Miss
• Negative Sentiment: Management issued cautious guidance: Q2 EPS $0.150–0.250 (consensus ~0.230) and FY26 EPS $0.700–1.100 (consensus ~1.00); revenue ranges are around or slightly below consensus. The guidance midpoint is generally conservative, which likely drove the stock decline. Q1 Results & Guidance

Analyst Ratings Changes

NUS has been the topic of a number of research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Thursday, January 22nd. Wall Street Zen lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. Finally, Zacks Research raised shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Nu Skin Enterprises presently has a consensus rating of “Hold”.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.